I understand the view that ACAD could make more $ if they kept the drug to themselves , but here's the problem ... ACAD does not and probably will never have the scale to manufacture , market and distribute a product nationwide and certainly not worldwide. Analogy : I own a fair sized commercial / industrial janitorial services company with about 130 employees that operates in 2 main cities in south central Va.. If we were to develope a unique cleaning product that met a need that no other product was effective on , we would have a goldmine ! But even though we knew how to make the stuff and use the stuff there is no way we could bring this product to market on a national scale without at least partnering with a national brand company. Still would be a pretty sweet deal for us AND it will be a pretty sweet deal for ACAD when that happens !
Well if they want to do it alone they better get cracking and be prepared for a hostile takeover. There a several major player who could buy up every share for 2-3 BILLION in a blink of an eye.
Plenty of start-ups go the distance w/o partnering. It's not easy and takes diluting shares to raise capital, but all they have to do is hire the people to do it (Sales Team, expand the Legal & Regulatory Team, hire a Contractor to build the facilities and hire the Operations Team). Time and Money is all it takes.
guru2003 - fair enough ... My point is that they would not have enough time or money. I'm not being critical of ACAD (it is my largest holding and as I write it is my largest profit investment ever , and I'm no kid) , just expressing my logic. As a few other posters have stated , I agree that the management team has done a masterful job thus far. Congrats to them and congrats to the longs.
All true, but somehow I lack confidence that ACAD's management team can bring it off. Their current corporation headcount is what, 25 or 30? In any case, the share price is only going up from here whichever route they take.
There are plenty of high quality contract manufacturers who can get that part done, under ACAD's supervision. Sales & marketing are much harder to manage and here they will need help. Also for ex-U.S. clinical development, regulatory approvals and sales & marketing.
I suspect they will go with a single partner world-wide, or else be acquired outright.
So are you saying that Pimavanserin is not only effective against Parkinson's Disease Psychosis, and possibly Alzheimer's disease Psychosis, but is also a miracualous cleaning product?
You could clean the care facilities with what's left over - wow!